Abstract
The use of plants for the prevention, diagnosis, treatment, and improvement of diseases dates back to antiquity and has been widely employed in traditional medicine. Among the various plant families, the Zingiberaceae family has garnered special attention due to its ability to produce beneficial bioactive substances for the food, pharmaceutical, and cosmetic industries. A prominent member of this family is Curcuma longa, commonly known as turmeric or saffron, which contains a compound called curcumin that possesses potential biopharmacological activity. Curcumin is considered safe by the American Food and Drug Administration (FDA) and does not exhibit any side effects when consumed in moderate amounts. Numerous studies have been conducted on curcumin due to its therapeutic potential in various diseases, particularly in neurodegenerative disorders such as Alzheimer’s disease. Research indicates that this substance holds remarkable potential as an effective and safe treatment. In this context, this chapter focuses on the characteristics of C. longa and reviews studies related to the use of curcumin in treating Alzheimer’s disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aggarwal BB (2010) Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr 30(1):173–199. https://doi.org/10.1146/annurev.nutr.012809.104755
Banerjee R (2014) Effect of curcumin on the metal ion induced fibrillization of amyloid-β peptide. Spectrochim Acta Part A Mol Biomol Spectrosc 117:798–800. https://doi.org/10.1016/j.saa.2013.09.064
Banji OJF, Banji D, Ch K (2014) Curcumin and hesperidin improve cognition by suppressing mitochondrial dysfunction and apoptosis induced by D-galactose in rat brains. Food Chem Toxicol 74:51–59. https://doi.org/10.1016/j.fct.2014.08.020
Barnham KJ, Bush AI (2008) Metals in Alzheimer’s and Parkinson’s diseases. Curr Opin Chem Biol 12(2):222–228. https://doi.org/10.1016/j.cbpa.2008.02.019
Basnet P, Skalko-Basnet N (2011) Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 16(6):4567–4598. https://doi.org/10.3390/molecules16064567
Bassani TB, Turnes JM, Moura ELR, Bonato JM, Cóppola-Segovia V, Zanata SM, Oliveira RMMW, Vital MABF (2017) Effects of curcumin on short-term spatial and recognition memory, adult neurogenesis and neuroinflammation in a streptozotocin-induced rat model of dementia of Alzheimer’s type. Behav Brain Res 335:41–54. https://doi.org/10.1016/j.bbr.2017.08.014
Baum L, Lam CWK, Cheung SK-K, Kwok T, Lui V, Tsoh J, Lam L, Leung V, Hui E, Ng C, Woo J, Chiu HFK, Goggins WB, Zee BC-Y, Cheng KF, Fong CYS, Wong A, Mok H, Chow MSS, Ho PC (2008) Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer’s disease. J Clin Psychopharmacol 28(1):110–113. https://doi.org/10.1097/jcp.0b013e318160862c
Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O (2012) Oxidative stress and antioxidant defense. World Allergy Organ J 5(1):9–19. https://doi.org/10.1097/wox.0b013e3182439613
Chandran B, Goel A (2012) A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res 26(11):1719–1725. https://doi.org/10.1002/ptr.4639
Chartier-Harlin M-C, Parfitt M, Legrain S, Pérez-Tur J, Brousseau T, Evans A, Berr C, Vldal O, Roques P, Gourlet V, Fruchart J-C, Delacourte A, Rossor M, Amouyel P (1994) Apolipoprotein E, ɛ4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer’s disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 3(4):569–574. https://doi.org/10.1093/hmg/3.4.569
Chen Z-R, Huang J-B, Yang S-L, Hong F-F (2022a) Role of cholinergic signaling in Alzheimer’s disease. Molecules 27(6):1816. https://doi.org/10.3390/molecules27061816
Chen P, Yao H, Tijms BM, Wang P, Wang D, Song C, Yang H, Zhang Z, Zhao K, Qu Y, Kang X, Du K, Fan L, Han T, Yu C, Zhang X, Jiang T, Zhou Y, Lu J, Han Y (2022b) Four distinct subtypes of Alzheimer’s disease based on resting-state connectivity biomarkers. Biol Psychiatry 93:759–769. https://doi.org/10.1016/j.biopsych.2022.06.019
Cianciulli A, Calvello R, Porro C, Trotta T, Salvatore R, Panaro MA (2016) PI3k/Akt signaling pathway plays a crucial role in the anti-inflammatory effects of curcumin in LPS-activated microglia. Int Immunopharmacol 36:282–290. https://doi.org/10.1016/j.intimp.2016.05.007
Coradini K, César D, Altenhofen S, Reolon GK, Nery LR, Silva NJ, Monica, Bonan CD, Ruver C (2021) Free and nano encapsulated curcumin prevents scopolamine-induced cognitive impairment in adult zebrafish. J Drug Deliv Sci Technol 66:102781–102781. https://doi.org/10.1016/j.jddst.2021.102781
Cox KH, Pipingas A, Scholey AB (2014) Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psychopharmacol 29(5):642–651. https://doi.org/10.1177/0269881114552744
Cristóvão JS, Santos R, Gomes CM (2016) Metals and neuronal metal binding proteins implicated in Alzheimer’s disease. Oxidative Med Cell Longev 2016:9812178. https://doi.org/10.1155/2016/9812178
Di Martino RMC, De Simone A, Andrisano V, Bisignano P, Bisi A, Gobbi S, Rampa A, Fato R, Bergamini C, Perez DI, et al. (2016) Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors. J Med Chem 59:531–544. https://doi.org/10.1021/acs.jmedchem.5b00894
Ding L, Li J, Song B, Xiao X, Zhang B, Qi M, Huang W, Yang L, Wang Z (2016) Curcumin rescues high-fat diet-induced obesity and insulin sensitivity in mice by regulating SREBP pathway. Toxicol Appl Pharmacol 304:99–109. https://doi.org/10.1016/j.taap.2016.05.011
Dong S, Zeng Q, Mitchell ES, Xiu J, Duan Y, Li C, Tiwari JK, Hu Y, Cao X, Zhao Z (2012) Curcumin enhances neurogenesis and cognition in aged rats: implications for transcriptional interactions related to growth and synaptic plasticity. PLoS ONE 7(2):e31211. https://doi.org/10.1371/journal.pone.0031211
Duarte R, Bovi OA, Maia NB (1989) Corantes - Programa de Pesquisa do Instituto Agronômico de Campinas. Seminário Corantes Naturais. Ourucum. https://www.ourucum.com.br/seminario-corantes-naturais
El-Agamy DS (2010) Comparative effects of curcumin and resveratrol on aflatoxin B1-induced liver injury in rats. Arch Toxicol 84(5):389–396. https://doi.org/10.1007/s00204-010-0511-2
Essa R, El Sadek AM, Baset ME, Rawash MA, Sami DG, Badawy MT, Mansour ME, Attia H, Saadeldin MK, Abdellatif A (2019) Effects of turmeric (Curcuma longa) extract in streptozocin-induced diabetic model. J Food Biochem 43(9). https://doi.org/10.1111/jfbc.12988
Finefrock AE, Bush AI, Murali Doraiswamy P (2003) Current status of metals as therapeutic targets in Alzheimer’s disease. J Am Geriatr Soc 51(8):1143–1148. https://doi.org/10.1046/j.1532-5415.2003.51368.x
Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102(4):1095–1104. https://doi.org/10.1111/j.1471-4159.2007.04613.x
Gibellini L, Bianchini E, De Biasi S, Nasi M, Cossarizza A, Pinti M (2015) Natural compounds modulating mitochondrial functions. Evid Based Complement Alternat Med 2015:1–13. https://doi.org/10.1155/2015/527209
Gupta SC, Patchva S, Koh W, Aggarwal BB (2012) Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 39(3):283–299. https://doi.org/10.1111/j.1440-1681.2011.05648.x
Gupta SC, Kismali G, Aggarwal BB (2013) Curcumin, a component of turmeric: from farm to pharmacy. Biofactors 39:2–13. https://doi.org/10.1002/biof.1079
Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R (2011) Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21(10):718–779. https://doi.org/10.1016/j.euroneuro.2011.08.008
Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide. Nat Rev Mol Cell Biol 8(2):101–112. https://doi.org/10.1038/nrm2101
Hoppe JB, Coradini K, Frozza RL, Oliveira CM, Meneghetti AB, Bernardi A, Pires ES, Beck RCR, Salbego CG (2013) Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway. Neurobiol Learn Mem 106:134–144. https://doi.org/10.1016/j.nlm.2013.08.001
Huang H-C, Tang D, Xu K, Jiang Z-F (2013) Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway. J Recept Signal Transduct 34(1):26–37. https://doi.org/10.3109/10799893.2013.848891
Ishrat T, Hoda MN, Khan MB, Yousuf S, Ahmad M, Khan M, M., Ahmad, A., & Islam, F. (2009) Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer’s type (SDAT). Eur Neuropsychopharmacol 19(9):636–647. https://doi.org/10.1016/j.euroneuro.2009.02.002
Ittner LM, Götz J (2010) Amyloid-β and tau - a toxic pas de deux in Alzheimer’s disease. Nat Rev Neurosci 12(2):67–72. https://doi.org/10.1038/nrn2967
Iweala EJ, Uche ME, Dike ED, Etumnu LR, Dokunmu TM, Oluwapelumi AE, Okoro BC, Dania OE, Adebayo AH, Ugbogu EA (2023) Curcuma longa (turmeric): ethnomedicinal uses, phytochemistry, pharmacological activities and toxicity profiles—a review. Pharmacol Res 6:100222. https://doi.org/10.1016/j.prmcm.2023.100222
Jagtap S, Meganathan K, Wagh V, Winkler J, Hescheler J, Sachinidis A (2009) Chemoprotective mechanism of the natural compounds, epigallocatechin-3-o-gallate, quercetin and curcumin against cancer and cardiovascular diseases. Curr Med Chem 16(12):1451–1462. https://doi.org/10.2174/092986709787909578
Judd WS, Al E (2009) Sistemática vegetal: um enfoque filogenético. Artmed, Yerevan
Kim HJ, Park EC, Joe E-H, Jou I (2003) Curcumin suppresses janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J Immunol 171(11):6072–6079. https://doi.org/10.4049/jimmunol.171.11.6072
Kinney SRM, Carlson L , Ser-Dolansky J, Thompson C, Shah S, Gambrah A, Xing W, Schneider SS, Mathias CB (2015) Curcumin Ingestion Inhibits Mastocytosis and Suppresses Intestinal Anaphylaxis in a Murine Model of Food Allergy PLOS ONE 10(7):e0132467. https://doi.org/10.1371/journal.pone.0132467
Lameira OA, Brasil E (2008) Plantas medicinais: do cultivo, manipulação e uso à recomendação popular. Embrapa Amazônia Oriental, Belém
Lee H-Y, Kim S-W, Lee G-H, Choi M-K, Chung H-W, Lee Y-C, Kim H-R, Kwon HJ, Chae H-J (2017) Curcumin and Curcuma longa L. extract ameliorate lipid accumulation through the regulation of the endoplasmic reticulum redox and ER stress. Sci Rep 7(1):6513. https://doi.org/10.1038/s41598-017-06872-y
Liao VH-C, Yu C-W, Chu Y-J, Li W-H, Hsieh Y-C, Wang T-T (2011) Curcumin-mediated lifespan extension in Caenorhabditis elegans. Mech Ageing Dev 132(10):480–487. https://doi.org/10.1016/j.mad.2011.07.008
Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21(21):8370–8377. https://doi.org/10.1523/JNEUROSCI.21-21-08370.2001
Magalingam KB, Radhakrishnan A, Ping NS, Haleagrahara N (2018) Current Concepts of Neurodegenerative Mechanisms in Alzheimer’s Disease. BioMed Res Int 2018:1–12. https://doi.org/10.1155/2018/3740461
Mirzaei H, Shakeri A, Rashidi B, Jalili A, Banikazemi Z, Sahebkar A (2017) Phytosomal curcumin: a review of pharmacokinetic, experimental and clinical studies. Biomed Pharmacother 85:102–112. https://doi.org/10.1016/j.biopha.2016.11.098
Monroy A, Lithgow GJ, Alavez S (2013) Curcumin and neurodegenerative diseases. Biofactors 39:122–132. https://doi.org/10.1002/biof.1063
Nam SM, Choi JH, Yoo DY, Kim W, Jung HY, Kim JW, Yoo M, Lee S, Kim CJ, Yoon YS, Hwang IK (2014) Effects of curcumin (Curcuma longa) on learning and spatial memory as well as cell proliferation and neuroblast differentiation in adult and aged mice by upregulating brain-derived neurotrophic factor and CREB signaling. J Med Food 17(6):641–649. https://doi.org/10.1089/jmf.2013.2965
Nicoliche T, Maldonado DC, Faber J, Silva MCP (2020) Evaluation of the articular cartilage in the knees of rats with induced arthritis treated with curcumin. PLoS ONE 15(3):e0230228. https://doi.org/10.1371/journal.pone.0230228
Oliveira CBC, Brito LA, Freitas MA, Souza MPA, Rêgo JMC, Machado RJDA (2020) Obesidade: inflamação e compostos bioativos. J Health Biol Sci 8(1):1. https://doi.org/10.12662/2317-3076jhbs.v8i1.2785.p1-5.2020
Ono K, Hasegawa K, Naiki H, Yamada M (2004) Curcumin has potent anti-amyloidogenic effects for Alzheimer’s? Amyloid fibrils in vitro. J Neurosci Res 75(6):742–750. https://doi.org/10.1002/jnr.20025
Orth M, Bellosta S (2012) Cholesterol: its regulation and role in central nervous system disorders. Cholesterol 2012:1–19. https://doi.org/10.1155/2012/292598
Ozansoy M, Mikati H, Velioglu HM, Yulug B (2023) Exosomes: a missing link between chronic systemic inflammation and Alzheimer’s disease? Biomed Pharmacother 159:114161–114161. https://doi.org/10.1016/j.biopha.2022.114161
Persson T, Popescu BO, Cedazo-Minguez A (2014) Oxidative stress in Alzheimer’s disease: why did antioxidant therapy fail? Oxidative Med Cell Longev 2014:1–11. https://doi.org/10.1155/2014/427318
Picciano AL, Vaden TD (2013) Complexation between Cu(II) and curcumin in the presence of two different segments of amyloid β. Biophys Chem 184:62–67. https://doi.org/10.1016/j.bpc.2013.09.004
Popp J, Meichsner S, Kölsch H, Lewczuk P, Maier W, Kornhuber J, Jessen F, Lütjohann D (2013) Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer’s disease. Eur Netw Oxysterol Res 86(1):37–42. https://doi.org/10.1016/j.bcp.2012.12.007
Priyadarsini K (2014) The chemistry of curcumin: from extraction to therapeutic agent. Molecules 19:20091–20112. https://doi.org/10.3390/molecules191220091
Rainey-Smith SR, Brown BM, Sohrabi HR, Shah T, Goozee KG, Gupta VB, Martins RN (2016) Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults. Br J Nutr 115(12):2106–2113. https://doi.org/10.1017/S0007114516001203
Rao EV, Sudheer P (2011) Revisiting curcumin chemistry part I: a new strategy for the synthesis of curcuminoids. Indian J Pharm Sci 73:93508. https://doi.org/10.4103/0250-474x.93508
Rane JS, Bhaumik P, Panda D (2017) Curcumin inhibits tau aggregation and disintegrates preformed tau filaments in vitro. J Alzheimers Dis 60(3):999–1014. https://doi.org/10.3233/jad-170351
Reinke AA, Gestwicki JE (2007) Structure–activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility. Chem Biol Drug Des 70(3):206–215. https://doi.org/10.1111/j.1747-0285.2007.00557.x
Rulon LL, Robertson JD, Lovell MA, et al. (2000) Serum zinc levels and Alzheimer’s disease. Biol Trace Elem Res 75:79–85. https://doi.org/10.1385/BTER:75:1-3:79
Sakai H, Kai Y, Oguchi A, Kimura M, Tabata S, Yaegashi M, Saito T, Sato K, Sato F, Yumoto T, Narita M (2016) Curcumin inhibits 5-fluorouracil-induced up-regulation of CXCL1 and CXCL2 of the colon associated with attenuation of diarrhoea development. Basic Clin Pharmacol Toxicol 119(6):540–547. https://doi.org/10.1111/bcpt.12619
Sandhir R, Yadav A, Mehrotra A, Sunkaria A, Singh A, Sharma S (2013) Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington’s disease. NeuroMolecular Med 16(1):106–118. https://doi.org/10.1007/s12017-013-8261-y
Shi X, Zheng Z, Li J, Xiao Z, Qi W, Zhang A, Wu Q, Fang Y (2015) Curcumin inhibits Aβ-induced microglial inflammatory responses in vitro: involvement of ERK1/2 and p38 signaling pathways. Neurosci Lett 594:105–110. https://doi.org/10.1016/j.neulet.2015.03.045
Singh S, Kumar P (2016) Neuroprotective potential of curcumin in combination with piperine against 6-hydroxy dopamine induced motor deficit and neurochemical alterations in rats. Inflammopharmacology 25(1):69–79. https://doi.org/10.1007/s10787-016-0297-9
Small GW, Siddarth P, Li Z, Miller KJ, Ercoli L, Emerson ND, Martinez J, Wong K-P, Liu J, Merrill DA, Chen ST, Henning SM, Satyamurthy N, Huang S-C, Heber D, Barrio JR (2018) Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults: a double-blind, placebo-controlled 18-month trial. Am J Geriatr Psychiatry 26(3):266–277. https://doi.org/10.1016/j.jagp.2017.10.010
Souza VC, Lorenzi H (2012) Botânica sistemática: Guia ilustrado para identificação das famílias de Fanerógamas nativas e exóticas no Brasil, baseado em APG III, 3rd edn. Instituto Plantarum de Estudos da Flora LTDA, Nova Odessa
Squitti R (2012) Copper dysfunction in Alzheimer’s disease: from meta-analysis of biochemical studies to new insight into genetics. J Trace Elem Med Biol 26(2-3):93–96. https://doi.org/10.1016/j.jtemb.2012.04.012
Sueth-Santiago V, Mendes-Silva GP, Decoté-Ricardo D, Edilson M (2015) Curcumin, the golden powder from turmeric: insights into chemical and biological activities. Quím Nova 38:4. https://doi.org/10.5935/0100-4042.20150035
Sundaram JR, Poore CP, Sulaimee NHB, Pareek T, Cheong WF, Wenk MR, Pant HC, Frautschy SA, Low C-M, Kesavapany S (2017) Curcumin ameliorates neuroinflammation, neurodegeneration, and memory deficits in p25 transgenic mouse model that bears hallmarks of Alzheimer’s disease. J Alzheimers Dis 60(4):1429–1442. https://doi.org/10.3233/JAD-170093
Thapa A, Jett SD, Chi EY (2015) Curcumin attenuates amyloid-β aggregate toxicity and modulates amyloid-β aggregation pathway. ACS Chem Neurosci 7(1):56–68. https://doi.org/10.1021/acschemneuro.5b00214
Tung BT, Nham DT, Hai NT, Thu DK (2019) Chapter 10 - curcuma longa, the polyphenolic curcumin compound and pharmacological effects on liver. In: Watson RR, Preedy VR (eds) Dietary interventions in liver disease. Academic, New York, pp 125–134. https://doi.org/10.1016/B978-0-12-814466-4.00010-0
Voulgaropoulou SD, van Amelsvoort TAMJ, Prickaerts J, Vingerhoets C (2019) The effect of curcumin on cognition in Alzheimer’s disease and healthy aging: a systematic review of pre-clinical and clinical studies. Brain Res 1725:146476. https://doi.org/10.1016/j.brainres.2019.146476
Wang Y, Yin H, Lou J, Han B, Qin X, Meng F, Geng S, Liu Y (2011) Effects of curcumin on hippocampal Bax and Bcl-2 expression and cognitive function of a rat model of Alzheimer’s disease. Neural Regen Res 6:1845–1849. https://doi.org/10.3969/j.issn.1673-5374.2011.24.001
Xiong Z, Hongmei Z, Lu S, Yu L (2011) Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer’s disease. Pharmacol Rep 63(5):1101–1108. https://doi.org/10.1016/s1734-1140(11)70629-6
Xu L, Ding L, Su Y, Shao R, Liu J, Huang Y (2019) Neuroprotective effects of curcumin against rats with focal cerebral ischemia-reperfusion injury. Int J Mol Med 43:4094. https://doi.org/10.3892/ijmm.2019.4094
Xue-Shan Z, Juan P, Qi W, Zhong R, Li-Hong P, Zhi-Han T, Zhi-Sheng J, Gui-Xue W, Lu-Shan L (2016) Imbalanced cholesterol metabolism in Alzheimer’s disease. Clin Chim Acta 456:107–114. https://doi.org/10.1016/j.cca.2016.02.024
Yanagisawa D, Ibrahim NF, Taguchi H, Morikawa S, Hirao K, Shirai N, Sogabe T, Tooyama I (2015) Curcumin derivative with the substitution at C-4 position, but not curcumin, is effective against amyloid pathology in APP/PS1 mice. Neurobiol Aging 36(1):201–210. https://doi.org/10.1016/j.neurobiolaging.2014.07.041
Yuan HY, Kuang SY, Zheng X, Zheng X, Ling H, Yang Y, Yan P, Li K, Liao DF (2008) Curcumin inhibits cellular cholesterol accumulation by regulating SREBP-1/caveolin-1 signaling pathway in vascular smooth muscle cells. Acta Pharmacol Sin 29:555–563. https://doi.org/10.1111/j.1745-7254.2008.00783.x
Yugay D, Goronzy DP, Kawakami LM, Claridge SA, Song T, Yan Z, Xie Y, Gilles J, Yang Y, Weiss PS (2016) Copper Ion Binding Site in β-Amyloid Peptide. Nano Letters 16(10):6282–6289. https://doi.org/10.1021/acs.nanolett.6b02590
Zhang L, Fiala M, Cashman J, Sayre J, Espinosa A, Mahanian M, Zaghi J, Badmaev V, Graves MC, Bernard G, Rosenthal M (2006) Curcuminoids enhance amyloid-β uptake by macrophages of Alzheimer’s disease patients. J Alzheimers Dis 10(1):1–7. https://doi.org/10.3233/jad-2006-10101
Zhang L, Fang Y, Xu Y, Lian Y, Xie N, Wu T, Zhang H, Sun L, Zhang R, Wang Z (2015) Curcumin improves amyloid β-peptide (1-42) induced spatial memory deficits through BDNF-ERK signaling pathway. PLoS ONE 10(6). https://doi.org/10.1371/journal.pone.0131525
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Meneses, A.K.S., Salazar, G.J.T., de Freitas, M.M., de Lima, S.G. (2023). Curcuma longa: A Natural Ally in Alzheimer’s Disease Management. In: Rai, M., Feitosa, C.M. (eds) Curcumin and Neurodegenerative Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-99-7731-4_9
Download citation
DOI: https://doi.org/10.1007/978-981-99-7731-4_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-7730-7
Online ISBN: 978-981-99-7731-4
eBook Packages: MedicineMedicine (R0)